Our people–a story of
competence and collaboration


Cultivating a diverse set of expertise and knowledge.

We employ an exemplary set of professionals with diverse skill sets, all working toward a common goal—invested in the health and care of the patient, knowing financial returns follow well-being. Our people have come together from all over the world and represent a culture of competence and collaboration that is shaping Nan Fung Life Sciences for generations to come.


We’re solving critical challenges. Be part of the answer.
Meet our exemplary team


Arcutis Announces Positive Topline Results from ARRECTOR Pivotal Phase 3 Trial of Roflumilast Foam 0.3% in Scalp and Body Psoriasis

Study met both co-primary endpoints and all secondary endpoints. At week eight, 67.3% of individuals treated with roflumilast foam achieved…

Rallybio Announces Positive Preliminary Results for RLYB212, an anti-HPA-1a Monoclonal Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia

NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB) today announced positive preliminary results from its ongoing Phase 1b proof-of-concept study of…

Evommune Initiates Phase 2a Proof-of-Concept Clinical Trial to Evaluate EVO101 in Atopic Dermatitis

Palo Alto, Calif., Sept. 28, 2022 – Evommune, Inc., a clinical-stage biotechnology company discovering and developing new ways to treat…

Plexium Strengthens Leadership Team With Appointment of Daniel Sipes As Senior Vice President, Head of Technology

Plexium, Inc. (Plexium), a leading next-generation targeted protein degradation (TPD) company, today announced the appointment of Daniel Sipes as Senior…